1. |
Liu M, Wu B, Wang WZ, et al. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol, 2007, 6(5): 456-464.
|
2. |
Heinsius T, Bogousslavsky J, Van Melle G. Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns. Neurology, 1998, 50(2): 341-350.
|
3. |
Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 2014, 45(4): 1222-1238.
|
4. |
Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993, 24(1): 35-41.
|
5. |
WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke--1989. recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke, 1989, 20(10): 1407-1431.
|
6. |
Torbey MT, Bosel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine. Neurocrit Care, 2015, 22(1): 146-164.
|
7. |
van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke, 1988, 19(5): 604-607.
|
8. |
Tsao JW, Hemphill JC, Johnston SC, et al. Initial Glasgow coma scale score predicts outcome following thrombolysis for posterior circulation stroke. Arch Neurol, 2005, 62(7): 1126-1129.
|
9. |
Giossi A, Volonghi I, Del Zotto E, et al. Large middle cerebral artery and panhemispheric infarction. Front Neurol Neurosci, 2012, 30: 154-157.
|
10. |
Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial[Hamlet]): a multicentre, open, randomised trial. Lancet Neurol, 2009, 8(4): 326-333.
|
11. |
Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial) Stroke, 2007, 38(9): 2506-2517.
|
12. |
Juttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke, 2007, 38(9): 2518-2525.
|
13. |
Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation, 2008, 118(15): e523-e661.
|
14. |
Wartenberg, KE. Malignant middle cerebral artery infarction. Curr Opin Crit Care, 2012, 18(2): 152-163.
|
15. |
Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med, 2011, 365(11): 993-1003.
|
16. |
Hacke W, Schwab S, Horn M, et al. ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol, 1996, 53(4): 309-315.
|
17. |
Kasner SE, Demchuk AM, Berrouschot J, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke, 2001, 32(9): 2117-2123.
|
18. |
Wang KW, Chang WN, Ho JT, et al. Factors predictive of fatality in massive middle cerebral artery territory infarction and clinical experience of decompressive hemicraniectomy. Eur J Neurol, 2006, 13(7): 765-771.
|
19. |
Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke, 2001, 32(12): 2735-2740.
|
20. |
吴丽峨, 刘鸣, 张月辉, 等. 缺血性脑卒中TOAST病因分型和预后. 中华神经科杂志, 2004, 37(4): 292-295.
|
21. |
Chobanian AV, Bakris GL, Black HR. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. JAMA, 2003, 12(4): 31-32.
|
22. |
Ng LK, Nimmannitya J. Massive cerebral infarction with severe brain swelling: a clinicopathological study. Stroke, 1970, 1(3): 158-163.
|
23. |
Jaramillo A, Gongora-Rivera F, Labreuche J, et al. Predictors for malignant middle cerebral artery infarctions: a postmortem analysis. Neurology, 2006, 66(6): 815-820.
|
24. |
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an Independent risk factor for stroke: the Framingham Study. Stroke, 1991, 22(8): 983-988.
|
25. |
Stead LG, Gilmore RM, Vedula KC, et al. Impact of acute blood pressure variability on ischemic stroke outcome. Neurology. 2006, 66(12): 1878-1881.
|
26. |
Liu FD, Benashski SE, Persky R, et al. Age-related changes in AMP-activated protein kinase after stroke. Age (Dordr), 2012, 34(1): 157-168.
|
27. |
Minnerup J, Wersching H, Ringelstein EB, et al. Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements. Stroke, 2011, 42(12): 3403-3409.
|
28. |
Bektas H, Wu TC, Kasam M, et al. Increased blood-brain barrier permeability on perfusion CT might predict malignant middle cerebral artery infarction. Stroke, 2010, 41(11): 2539-2544.
|
29. |
Foerch C, Otto B, Singer OC, et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke, 2004, 35(9): 2160-2164.
|